Member Login
  1. Stocks
    2. /
  2. Indivior PLC (LSE: INDV)
    3. /

LSE:INDV (Indivior PLC)

About INDV

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Indivior PLC (LSE: INDV) Latest News

    Investing Articles

    Why I think Indivior plc is a growth stock for shrewd investors

    | Rupert Hargreaves

    You shouldn't count out Indivior plc (LSE: INDV) just yet.

    Read more »

    Investing Articles

    Why I’d avoid Indivior plc today after shares crash 35%

    | Peter Stephens

    Indivior plc (LON: INDV) is one of today's major fallers.

    Read more »

    Investing Articles

    This great value stock is a better bet than Sirius Minerals plc

    | Royston Wild

    Royston Wild looks at a stock with more investment appeal than Sirius Minerals plc (LON: SXX).

    Read more »

    Investing Articles

    2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc

    | Jack Tang

    Should you buy Indivior plc (LON:INDV) and Impellam Group plc (LON:IPEL) as value plays following today's announcements?

    Read more »

    Investing Articles

    These 2 FTSE 250 flyers are up 60% in just 12 months

    | Harvey Jones

    Investors in these two FTSE 250 (INDEXFTSE:MCX) companies have plenty to celebrate, says Harvey Jones.

    Read more »

    Investing Articles

    2 top value stocks you should consider buying right now

    | Royston Wild

    Royston Wild runs the rule over two white-hot bargain stocks.

    Read more »

    Investing Articles

    Will this spin-off stock continue to slay FTSE 100 giants?

    | Roland Head

    Roland Head asks if this potential FTSE 100 (INDEXFTSE:UKX) giant killer is worth the risk.

    Read more »

    Investing Articles

    2 fast-growing FTSE 250 stocks for a prosperous 2017

    | Roland Head

    It could pay to take a closer look at these surprise winners, says Roland Head.

    Read more »

    Investing Articles

    Why AstraZeneca plc may still not be cheap enough to beat this upstart

    | Roland Head

    Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative.

    Read more »

    Investing Articles

    The Good, the Bad and the Ugly of pharma stocks

    | Bilaal Mohamed

    Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector.

    Read more »

    Investing Articles

    Should you snap up these two big fallers today?

    | Alan Oscroft

    We've got some big movers today, and share price falls can lead to nice bargains. Are these two worth snapping…

    Read more »

    Investing Articles

    3 hot shares to buy after today’s gains?

    | Alan Oscroft

    An unexpected share price movement could signal time to buy.

    Read more »